Search

Your search keyword '"Dawson, Charlie"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Dawson, Charlie" Remove constraint Author: "Dawson, Charlie"
171 results on '"Dawson, Charlie"'

Search Results

14. Customer responsiveness: Getting it fast and right through impatience and intolerance

15. Drug Price Reform: The Implications for 2022 and Beyond.

17. HER2CLIMB Trial Results Confirm Survival Benefit with Tucatinib in HER2-Positive Breast Cancer.

18. Best Practices for Optimizing Opioid Therapy in Patients with Cancer Pain.

19. Books: A new take on innovation

20. Books: A panoramic vision of the marketplace

21. Axicabtagene Ciloleucel Demonstrates Durable Clinical Benefit in High-Risk Large B-Cell Lymphoma.

22. Research Reveals Barriers to Clinical Trial Participation.

24. Standard of Care for Newly Diagnosed Multiple Myeloma Is Still Bortezomib, Lenalidomide, and Dexamethasone.

25. Marketing speak

27. All or nothing

28. Pilot Study Shows Clinical Benefit with Nivolumab in Pediatric Patients with Hypermutant Cancers.

29. Pharmacist-Driven Intervention Leads to Significant Increase in Biosimilar Adoption.

30. Clinical NCCN Risk Classifcation Suboptimal for Some African-American Men with Prostate Cancer.

31. Analysis of Healthcare Claims Shows Encouraging Trend in the Use of Trastuzumab Biosimilars.

32. The Benefits of Advance Care Planning During the COVID-19 Pandemic.

33. Survey Reveals Ongoing Misconceptions and Concerns Regarding Biosimilars.

34. Immersion therapy Sending senior staff out to see things through customers' eyes is the most effective way to up satisfaction levels

36. Aspacytarabine Safe and Effective in Patients with AML Unfit for Intensive Chemotherapy.

41. New Opportunities in Clinical Trials and Drug Development After COVID-19.

42. Immunotherapy Continues to Transform the Treatment Landscape for Advanced NSCLC.

43. Updates on the Use of Anticoagulants for Cancer-Associated Thromboembolism.

47. Glofitamab Step-Up Dosing Leads to High Response Rates in Relapsed or Refractory NHL.

48. Mosunetuzumab Offers Safe and Effective Treatment Option for Older Patients with DLBCL.

49. Intervention Improves Quality of Life for Patients Experiencing Financial Toxicity.

50. Vodobatinib Effective in Patients with CML Regardless of Previous Ponatinib Therapy.

Catalog

Books, media, physical & digital resources